Charles A. & Betty Bott Cancer Center at Holy Redeemer receives Commission on Cancer accreditation with Commendation

The hospital’s Cancer Program met 34 quality care standards

Holy Redeemer Hospital recently received three-year accreditation with Silver-Level Commendation from the Commission on Cancer, a quality program of the American College of Surgeons. To earn voluntary CoC accreditation, the hospital’s Cancer Program must meet 34 quality care standards, be evaluated every three years through a survey process and maintain levels of excellence in the delivery of comprehensive, patient-centered cancer care.

Holy Redeemer’s Cancer Program takes a multidisciplinary approach to treating cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists and other cancer specialties.

“Our Cancer Center team is proud of this accomplishment,” said Bott Cancer Center director Donna Miller, RN, MSN, CCCTM. “It is a reinforcement of our commitment to serve our community and provide quality care with dedicated and specially trained physicians for anyone faced with a diagnosis of cancer.”

Upon evaluation, Holy Redeemer’s Cancer Program was praised for its people-centered approach to cancer diagnosis and treatment. It is one of the few programs that continually addresses cancer patient distress screenings during pivotal clinical meetings.

“The three years since our last voluntary CoC accreditation have been a time of significant growth for the Bott Cancer Center with the development of several innovative oncology initiatives that will serve to further enhance the care of the wonderful patients we serve,” said Pallav Mehta, MD, medical director of the Bott Cancer Center.

The CoC Accreditation Program provides the framework for Holy Redeemer to improve its quality of cancer care through various programs that focus on the full spectrum of cancer care including prevention, early diagnosis, cancer staging, optimal treatment, rehabilitation, lifelong follow-up for recurrent disease and end-of-life care.

When patients receive care at a CoC facility, they also have access to information on clinical trials and new treatments, genetic counseling and patient-centered services including psycho-social support, a patient navigation process, and a survivorship care plan that documents the care each patient receives and seeks to improve cancer survivors’ quality of life.